We create and publish training materials and deal with the research of financial and commodity markets and identification of trading opportunities. We create information content in digital electronic form and its subsequent sale. We are not a stockbroker or broker, we are not financial institutions and we are not a financial intermediary.

20/12/17 15:40(CET)_Celsion_LONG

Celsion Long. The oncology company Celsion Corporation, which has a portfolio of innovative treatments for cancer, is paving the way for higher prices for its shares, CFDs. The current sad situation in the field of the global pandemic Covid 19 is resulting in a reduction in cancer treatment in mainstream workplaces and a move to private clinics. Celsion itself is one of the few to own patented products for successful treatment of this deadly disease. The current outlook for the rise in the price of CFDs, shares is at levels above 1 euro.

Chart and table source: WebTrader


Add comment

Your email address will not be published. Required fields are marked *

Your personal data will only be used for the processing of this comment. Principles of personal data processing